Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018612 · ClinicalTrials.gov registry record · Phase 2
A Study of Acetaminophen for Post Surgical Dental Pain
A Phase 2 study, sponsored by Nevakar.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT04018612 is a Phase 2 study that has completed, run by Nevakar. The registered enrollment target is 110 participants.
The verdict
NCT04018612, a Phase 2 study, has completed, sponsored by Nevakar.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
To assess the safety, tolerability, analgesic, efficacy and pharmacokinetics of high dose acetaminophen relative to placebo and low dose acetaminophen relative to placebo over a 24 hour period in patient experiencing moderate to severe pain following the surgical removal of third molar.
Interventions
- DRUG Acetaminophen
- OTHER Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-04-25 |
| Est. Completion | 2019-08-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04018612
The ClinicalTrials.gov registry entry for NCT04018612 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nevakar, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT04018612 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04018612 about?
NCT04018612 is a clinical study titled "A Study of Acetaminophen for Post Surgical Dental Pain". To assess the safety, tolerability, analgesic, efficacy and pharmacokinetics of high dose acetaminophen relative to placebo and low dose acetaminophen relative to placebo over a 24 hour period in patient experiencing moderate to severe pain following the surgical removal of third molar.
What is the current status of trial NCT04018612?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2019-04-25. Estimated completion is 2019-08-15.
What interventions are being tested in trial NCT04018612?
The interventions under investigation include: Acetaminophen (DRUG), Placebo (OTHER).
Who is sponsoring clinical trial NCT04018612?
This trial is sponsored by Nevakar, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.